PMA device
Kappa 400 Dr/Sr Ipgs
Medtronic, Inc. · Pulse Generator, Permanent, Implantable (NVZ, Class III) · First FDA decision Nov 21, 2008, newest May 13, 2011Bradycardia and heart blockHeart failure
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
4
PMA pathway
Device trials
0
Naming "Kappa 400 Dr"
MAUDE reports
13
Brand "Kappa 400 Dr", since 2015
PubMed studies
0
Mentioning "Kappa 400 Dr"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Kappa 400 Dr/Sr Ipgs
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 4 of 4 decisions filed under this name.
- KAPPA 400 DR/SR IPGSPMA supplement
P970012-S081 · Decided May 13, 2011 · 129 days after receipt · Normal 180 Day Track
Device type: Pulse generator, permanent, implantable (NVZ) · Cardiology
- KAPPA 400 DR/SR IPGPMA supplement
P970012-S068 · Decided Mar 22, 2011 · 309 days after receipt · Normal 180 Day Track
Device type: Pulse generator, permanent, implantable (NVZ) · Cardiology
- KAPPA 400 DR/SR IPGPMA supplement
P970012-S053 · Decided May 21, 2009 · 80 days after receipt · Normal 180 Day Track
Device type: Pulse generator, permanent, implantable (NVZ) · Cardiology
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Kappa 400 Dr", any status and sponsor, newest update first.
No registered device study names "Kappa 400 Dr".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Kappa 400 Dr", and for the whole product code for context.
This brand
13 reports: 0 malfunction, 13 injury, 0 death
Whole product code NVZ
72,953 reports: 32,608 malfunction, 38,411 injury, 1,913 death
Newest reports for this brand
- KAPPA 400 DRInjury
2182208-2018-01845 · Received Oct 11, 2018 · Event dated Dec 1, 2005
Device type: Pulse Generator, Permanent, Implantable (NVZ)
Device problem as coded: Over-Sensing; Pacing Problem
Patient problem as coded: No Known Impact Or Consequence To Patient
- KAPPA 400 DRInjury
2182208-2018-01846 · Received Oct 11, 2018 · Event dated Dec 1, 2005
Device type: Pulse Generator, Permanent, Implantable (NVZ)
Device problem as coded: Over-Sensing; Pacing Problem
Patient problem as coded: No Known Impact Or Consequence To Patient
- KAPPA 400 DRInjury
MDT PUERTO RICO OPERATIONS CO, MED REL
2647346-2018-00028 · Received Jun 21, 2018 · Event dated May 29, 2018
Device type: Pulse Generator, Permanent, Implantable (NVZ)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Unspecified Infection
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Medtronic Inc. Cardiac Rhythm Disease Managment
Z-1515-2009 · Started May 18, 2009 · Posted by FDA Jun 11, 2009
Reason given: One or more bond wire pairs will lift or separate from the bonding terminals on the device hybrid. This may present clinically as loss of rate response, premature battery depletion, loss of telemetry, or no output.
Cause as FDA categorized it: Device Design · Device type: Pulse Generator, Permanent, Implantable (NVZ)
Published research
The most relevant PubMed records for "Kappa 400 Dr"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code NVZ.
- CareLink Instruments & DDMA, CareLink SmartSync Common ApplicationMedtronic, Inc. · PMA 2023
- Affinity/Integrity/Victory/Zephyr/Accent Family of PacemakersAbbott Medical · PMA 2016
- Adapta, Versa, Sensia IPGEnPulse E1 IPG Kappa DR (Kappa 700/600)Medtronic, Inc. · PMA 2017
- Various Families of PacemakersMedtronic, Inc. · PMA 2008
- Cadence Family of IcdsAbbott Medical · PMA 2012
- Medtronic CareLink Monitor, CardioSight ReaderMedtronic, Inc. · PMA 2019
- Legend Plus Family of PacemakersMedtronic, Inc. · PMA 2011
- Advisa DR MRI SureScan Model A2DR01 IPG, Advisa SR MRI SureScan Model A3SR01 IPGMedtronic, Inc. · PMA 2022
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.